Qi Liu

Texas Heart Institute Positions

Assistant Research Investigator, Molecular Cardiology Research Lab

Publications

4862227 LV239TYN 1 alternatives-to-animal-experimentation 10 date desc Liu 1980 https://www.texasheart.org/wp-content/plugins/zotpress/

%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22VN7P27FL%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shi%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BShi%2C%20A.%2C%20El%20Haddad%2C%20J.%2C%20Cai%2C%20P.%20et%20al.%20%282023%29.%20Mpox%20%28monkeypox%29%20information%20on%20TikTok%3A%20analysis%20of%20quality%20and%20audience%20engagement.%20%26lt%3Bi%26gt%3BBMJ%20Glob%20Health%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%20e011138.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2022-011138%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2022-011138%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mpox%20%28monkeypox%29%20information%20on%20TikTok%3A%20analysis%20of%20quality%20and%20audience%20engagement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ao%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joe%22%2C%22lastName%22%3A%22El%20Haddad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shijie%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuan%20Jia%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pengyang%22%2C%22lastName%22%3A%22Li%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Online%20information%20on%20mpox%20%28monkeypox%29%20is%20not%20well%20studied.%20We%20have%20analysed%20the%20video%20content%2C%20information%20quality%2C%20and%20audience%20engagement%20of%20mpox-related%20videos%20on%20TikTok.%5CnMETHODS%3A%20Using%20a%20hashtag-based%20searching%20strategy%2C%20we%20identified%202462%20mpox-related%20videos%20on%20TikTok%20from%201%20January%20to%2011%20August%202022%3B%2085%20were%20included%20after%20exclusion%20criteria%20screening.%20Videos%20were%20evaluated%20for%20content%20on%20features%20and%20treatment%20of%20mpox.%20Video%20and%20information%20quality%20was%20assessed%20using%20the%20DISCERN%20instrument%20and%20the%20Journal%20of%20the%20American%20Medical%20Association%20%28JAMA%29%20criteria.%20We%20recorded%20video%20source%2C%20evaluation%20scores%2C%20and%20viewer%20engagement%20metrics.%20The%20Kruskal-Wallis%20test%20was%20used%20for%20statistical%20analysis%20and%20multiple%20linear%20regression%20for%20factor-association%20studies.%5CnRESULTS%3A%20Of%20the%2085%20videos%2C%20two%20assessed%20all%20content%20topics%20and%20highlighted%2033%25%20of%20all%20content%20items%20in%20clinical%20guidelines.%20The%20overall%20average%20score%20for%20the%20videos%20was%2039.56%20of%2080%20on%20the%20DISCERN%20instrument%20and%201.93%20of%204%20on%20the%20JAMA%20criteria.%20No%20video%20met%20all%20JAMA%20criteria.%20Subgroup%20analysis%20based%20on%20author%20identity%20suggested%20the%20variance%20in%20video%20scores%20by%20source%20%28p%26lt%3B0.05%20for%20all%29.%20Overall%20scores%20were%20higher%20for%20videos%20produced%20by%20doctors%20and%20science%20communicators%20than%20for%20those%20made%20by%20institutional%20users%2C%20nurses%2C%20and%20the%20general%20public.%20Multiple%20linear%20regression%20analysis%20showed%20that%20having%20people%20in%20the%20video%20%2869.20%2C%20p%3D0.0001%29%20and%20including%20information%20on%20treatment%20choices%20%281.15%2C%20p%3D0.045%29%20were%20significant%2C%20independent%20determinants%20of%20audience%20engagement.%5CnCONCLUSION%3A%20Public-directed%20TikTok%20videos%20on%20mpox%20frequently%20provide%20incomplete%2C%20inaccurate%20information%2C%20highlighting%20the%20potential%20risks%20of%20using%20TikTok%20as%20a%20health%20information%20source.%22%2C%22date%22%3A%222023-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjgh-2022-011138%22%2C%22ISSN%22%3A%222059-7908%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22LV239TYN%22%2C%22BNSCCUCI%22%5D%2C%22dateModified%22%3A%222023-06-08T13%3A52%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22UQ5DXLDA%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chen%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-16%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChen%2C%20X.%2C%20Yu%2C%20W.%2C%20Zhang%2C%20J.%20et%20al.%20%282023%29.%20Therapeutic%20angiogenesis%20and%20tissue%20revascularization%20in%20ischemic%20vascular%20disease.%20%26lt%3Bi%26gt%3BJ%20Biol%20Eng%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B17%26lt%3B%5C%2Fi%26gt%3B%2C%2013.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13036-023-00330-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs13036-023-00330-2%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Therapeutic%20angiogenesis%20and%20tissue%20revascularization%20in%20ischemic%20vascular%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinyue%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenlu%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%22%2C%22lastName%22%3A%22Fan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pengyang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ao%22%2C%22lastName%22%3A%22Shi%22%7D%5D%2C%22abstractNote%22%3A%22Ischemic%20vascular%20disease%20is%20a%20major%20healthcare%20problem.%20The%20keys%20to%20treatment%20lie%20in%20vascular%20regeneration%20and%20restoration%20of%20perfusion.%20However%2C%20current%20treatments%20cannot%20satisfy%20the%20need%20for%20vascular%20regeneration%20to%20restore%20blood%20circulation.%20As%20biomedical%20research%20has%20evolved%20rapidly%2C%20a%20variety%20of%20potential%20alternative%20therapeutics%20has%20been%20explored%20widely%2C%20such%20as%5Cu00a0growth%20factor-based%20therapy%2C%20cell-based%20therapy%2C%20and%20material-based%20therapy%20including%20nanomedicine%20and%20biomaterials.%20This%20review%20will%20comprehensively%20describe%20the%20main%20pathogenesis%20of%20vascular%20injury%20in%20ischemic%20vascular%20disease%2C%20the%20therapeutic%20function%20of%20the%20above%20three%20treatment%20strategies%2C%20the%20corresponding%20potential%20challenges%2C%20and%20future%20research%20directions.%22%2C%22date%22%3A%22Feb%2016%2C%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs13036-023-00330-2%22%2C%22ISSN%22%3A%221754-1611%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22LV239TYN%22%2C%22CH4JXISP%22%2C%22JD5ZU4IS%22%5D%2C%22dateModified%22%3A%222023-03-14T14%3A36%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22QLIMM6YA%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chen%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChen%2C%20X.%2C%20Cai%2C%20Q.%2C%20Liang%2C%20R.%20et%20al.%20%282023%29.%20Copper%20homeostasis%20and%20copper-induced%20cell%20death%20in%20the%20pathogenesis%20of%20cardiovascular%20disease%20and%20therapeutic%20strategies.%20%26lt%3Bi%26gt%3BCell%20Death%20Dis%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%20105.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41419-023-05639-w%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41419-023-05639-w%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Copper%20homeostasis%20and%20copper-induced%20cell%20death%20in%20the%20pathogenesis%20of%20cardiovascular%20disease%20and%20therapeutic%20strategies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinyue%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruikai%22%2C%22lastName%22%3A%22Liang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deju%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meiying%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yan%22%2C%22lastName%22%3A%22Xiong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minxuan%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pengyang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ao%22%2C%22lastName%22%3A%22Shi%22%7D%5D%2C%22abstractNote%22%3A%22Copper%20is%20a%20vital%20mineral%2C%20and%20an%20optimal%20amount%20of%20copper%20is%20required%20to%20support%20normal%20physiologic%20processes%20in%20various%20systems%2C%20including%20the%20cardiovascular%20system.%20Over%20the%20past%20few%20decades%2C%20copper-induced%20cell%20death%2C%20named%20cuproptosis%2C%20has%20become%20increasingly%20recognized%20as%20an%20important%20process%20mediating%20the%20pathogenesis%20and%20progression%20of%20cardiovascular%20disease%20%28CVD%29%2C%20including%20atherosclerosis%2C%20stroke%2C%20ischemia-reperfusion%20injury%2C%20and%20heart%20failure.%20Therefore%2C%20an%20in-depth%20understanding%20of%20the%20regulatory%20mechanisms%20of%20cuproptosis%20in%20CVD%20may%20be%20useful%20for%20improving%20CVD%20management.%20Here%2C%20we%20review%20the%20relationship%20between%20copper%20homeostasis%20and%20cuproptosis-related%20pathways%20in%20CVD%2C%20as%20well%20as%20therapeutic%20strategies%20addressing%20copper-induced%20cell%20death%20in%20CVD.%22%2C%22date%22%3A%22Feb%2011.%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41419-023-05639-w%22%2C%22ISSN%22%3A%222041-4889%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22LV239TYN%22%2C%22JD5ZU4IS%22%5D%2C%22dateModified%22%3A%222023-03-14T14%3A34%3A21Z%22%7D%7D%2C%7B%22key%22%3A%226YCSUJN8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Liu%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BLiu%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Q.%2C%20Pan%2C%20S.%2C%20Li%2C%20P.%20et%20al.%20%282023%29.%20Hippo%20pathway%20inhibition%20promotes%20metabolic%20adaptability%20and%20antioxidant%20response%20in%20myoblasts.%20%26lt%3Bi%26gt%3BSci%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%2C%202232.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-023-29372-8%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-023-29372-8%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hippo%20pathway%20inhibition%20promotes%20metabolic%20adaptability%20and%20antioxidant%20response%20in%20myoblasts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pengyang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%5D%2C%22abstractNote%22%3A%22Metabolic%20plasticity%20in%20a%20hostile%20environment%20ensures%20cell%20survival.%20We%20investigated%20whether%20Hippo%20pathway%20inhibition%20contributed%20to%20cell%20adaptations%20under%20challenging%20conditions.%20We%20examined%20metabolic%20profiles%20and%20fuel%20substrate%20choices%20and%20preferences%20in%20C2C12%20myoblasts%20after%20Hippo%20pathway%20inhibition%20via%20Salvador%20knockdown%20%28SAV1%20KD%29.%20SAV1%20KD%20induced%20higher%20ATP%20production%20and%20a%20more%20energetic%20phenotype.%20Bioenergetic%20profiling%20showed%20enhanced%20key%20mitochondrial%20parameters%20including%20spare%20respiratory%20capacity.%20SAV1%20KD%20cells%20showed%20markedly%20elevated%20glycolysis%20and%20glycolytic%20reserves%3B%20blocking%20other%20fuel-oxidation%20pathways%20enhanced%20mitochondrial%20flexibility%20of%20glucose%20oxidation.%20Under%20limited%20glucose%2C%20endogenous%20fatty%20acid%20oxidation%20increased%20to%20cope%20with%20bioenergetic%20stress.%20Gene%20expression%20patterns%20after%20SAV1%20KD%20suggested%20transcriptional%20upregulation%20of%20key%20metabolic%20network%20regulators%20to%20promote%20energy%20production%20and%20free%20radical%20scavenging%20that%20may%20prevent%20impaired%20lipid%20and%20glucose%20metabolism.%20In%20SAV1%20KD%20cells%2C%20sirtuin%20signaling%20was%20the%20top%20enriched%20canonical%20pathway%20linked%20with%20enhanced%20mitochondrial%20ATP%20production.%20Collectively%2C%20we%20demonstrated%20that%20Hippo%20pathway%20inhibition%20in%20SAV1%20KD%20cells%20induces%20multiple%20metabolic%20properties%2C%20including%20enhancing%20mitochondrial%20spare%20respiratory%20capacity%20or%20glycolytic%20reserve%20to%20cope%20with%20stress%20and%20upregulating%20metabolic%20pathways%20supporting%20elevated%20ATP%20demand%2C%20bioenergetics%2C%20and%20glycolysis%20and%20counteracting%20oxidative%20stress.%20In%20response%20to%20metabolic%20challenges%2C%20SAV1%20KD%20cells%20can%20increase%20fatty%20acid%20oxidation%20or%20glucose-coupled%20oxidative%20phosphorylation%20capacity%20to%20compensate%20for%20substrate%20limitations%20or%20alternative%20fuel%20oxidation%20pathway%20inhibition.%22%2C%22date%22%3A%22Feb%208%2C%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-023-29372-8%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22LV239TYN%22%2C%22CH4JXISP%22%2C%22JD5ZU4IS%22%5D%2C%22dateModified%22%3A%222023-03-14T14%3A34%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22XTWHIWQS%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-18%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLi%2C%20P.%2C%20Jin%2C%20C.%2C%20Cui%2C%20C.%20et%20al.%20%282022%29.%20Impact%20of%20family%20history%20of%20coronary%20artery%20disease%20on%20clinical%20outcomes%20in%20Takotsubo%20cardiomyopathy.%20%26lt%3Bi%26gt%3BJ%20Investig%20Med%26lt%3B%5C%2Fi%26gt%3B%2C%20jim-2021-002186.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fjim-2021-002186%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fjim-2021-002186%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20family%20history%20of%20coronary%20artery%20disease%20on%20clinical%20outcomes%20in%20Takotsubo%20cardiomyopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pengyang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chengyue%22%2C%22lastName%22%3A%22Jin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Can%22%2C%22lastName%22%3A%22Cui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shamita%20Alisa%22%2C%22lastName%22%3A%22Manohar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ling%22%2C%22lastName%22%3A%22Jin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xin%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%5D%2C%22abstractNote%22%3A%22Family%20history%20of%20coronary%20artery%20disease%20%28FHxCAD%29%20is%20a%20critical%20risk%20factor%20for%20CAD%2C%20underscoring%20the%20contribution%20of%20genetic%20factors%20to%20disease%20pathogenesis%20and%20susceptibility.%20Takotsubo%20cardiomyopathy%20%28TCM%29%20simulates%20the%20clinical%20features%20of%20and%20frequently%20coexists%20with%20CAD.%20However%2C%20the%20association%20between%20FHxCAD%20and%20TCM%20is%20unclear.%20Here%2C%20we%20retrospectively%20examined%20the%20impact%20of%20FHxCAD%20on%20in-hospital%20outcomes%20of%20patients%20with%20TCM.%20Using%20the%20National%20Inpatient%20Sample%20database%20%282016-2018%29%2C%20we%20identified%204733%20patients%20admitted%20to%20hospital%20with%20a%20primary%20diagnosis%20of%20TCM.%20We%20compared%20in-hospital%20outcomes%20and%20complications%20between%20TCM%20patients%20with%20%28n%3D646%2C%2013.7%25%29%20and%20without%20FHxCAD%20%28n%3D646%29%20in%20the%20unmatched%20and%20in%20a%20propensity-score%20matched%20cohort%20%281%3A1%20ratio%29.%20TCM%20with%20FHxCAD%20patients%20had%20a%20reduced%20incidence%20of%20cardiogenic%20shock%2C%20acute%20kidney%20injury%20%28AKI%29%2C%20and%20acute%20respiratory%20failure%20%28ARF%29%3B%20lower%20mortality%20rates%3B%20shorter%20length%20of%20stay%20%28LOS%29%3B%20and%20decreased%20total%20charge%20compared%20with%20TCM%20without%20FHxCAD%20patients%20%28p%26lt%3B0.05%29.%20In%20the%20matched%20cohort%2C%20TCM%20with%20FHxCAD%20patients%20%28vs%20TCM%20without%20FHxCAD%20patients%29%20had%20a%20lower%20incidence%20of%20cardiogenic%20shock%20%282.2%25%20vs%206.3%25%2C%20p%26lt%3B0.001%3B%20OR%200.33%2C%2095%25%20CI%200.18%20to%200.61%29%2C%20AKI%20%285.1%25%20vs%208.7%25%2C%20p%3D0.016%3B%20OR%200.57%2C%2095%25%20CI%200.36%20to%200.88%29%2C%20and%20ARF%20%285.7%25%20vs%2012.7%25%2C%20p%26lt%3B0.001%3B%20OR%200.42%2C%2095%25%20CI%200.28%20to%200.63%29%3B%20decreased%20in-hospital%20mortality%20%28%26lt%3B11%25%20vs%203.1%25%2C%20p%3D0.002%3B%20OR%200.2%2C%2095%25%20CI%200.07%20to%200.57%29%3B%20shorter%20LOS%20%282.66%5Cu00b11.96%20days%20vs%203.40%5Cu00b13.05%20days%2C%20p%26lt%3B0.001%29%3B%20and%20a%20reduced%20total%20charge%20%28p%3D0.001%29%2C%20respectively.%20FHxCAD%20was%20associated%20with%20favorable%20outcomes%20in%20both%20unmatched%20and%20propensity-matched%20cohorts.%22%2C%22date%22%3A%22July%2018%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fjim-2021-002186%22%2C%22ISSN%22%3A%221708-8267%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22LV239TYN%22%2C%22CH4JXISP%22%2C%222RCWVZ4F%22%5D%2C%22dateModified%22%3A%222022-08-02T14%3A40%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22L82S82KQ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dai%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDai%2C%20Q.%2C%20Li%2C%20P.%2C%20Bose%2C%20A.%20et%20al.%20%282022%29.%20Association%20of%20atrial%20fibrillation%20burden%20with%20in-hospital%20outcomes%20in%20patients%20with%20Takotsubo%20cardiomyopathy.%20%26lt%3Bi%26gt%3BAm%20J%20Med%20Sci%26lt%3B%5C%2Fi%26gt%3B%2C%20S0002-9629%2822%2900296%26%23x2013%3B8.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjms.2022.06.019%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjms.2022.06.019%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20atrial%20fibrillation%20burden%20with%20in-hospital%20outcomes%20in%20patients%20with%20Takotsubo%20cardiomyopathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiying%22%2C%22lastName%22%3A%22Dai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pengyang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhishek%22%2C%22lastName%22%3A%22Bose%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ling%22%2C%22lastName%22%3A%22Jin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%22%2C%22lastName%22%3A%22Laidlaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20effects%20of%20atrial%20fibrillation%20%28AF%29%20and%20its%20burden%20on%20in-hospital%20mortality%20in%20patients%20with%20Takotsubo%20cardiomyopathy%20%28TCM%29%20are%20unclear.%20Here%2C%20we%20examined%20the%20effect%20of%20AF%20and%20paroxysmal%20AF%20on%20in-hospital%20outcomes%20in%20patients%20with%20TCM.%5CnMETHODS%3A%20We%20used%20ICD-10%20codes%20to%20retrospectively%20identify%20patients%20with%20a%20primary%20diagnosis%20of%20TCM%20in%20the%20National%20Inpatient%20Sample%20database%202016-2018.%20We%20compared%20in-hospital%20outcomes%20in%20TCM%20patients%20with%20and%20without%20AF%20before%20and%20after%20propensity%20score%20matching.%20The%20effect%20of%20AF%20burden%20on%20outcomes%20was%20assessed%20in%20patients%20with%20paroxysmal%20AF%20and%20no%20AF.%5CnRESULTS%3A%20Of%20the%204%2C733%20patients%20with%20a%20primary%20diagnosis%20of%20TCM%2C%20650%20%2813.7%25%29%20had%20AF%2C%20and%204%2C083%20%2886.3%25%29%20did%20not.%20Of%20TCM%20patients%20with%20AF%2C%20368%20%2856.6%25%29%20had%20paroxysmal%20AF.%20In-hospital%20mortality%20was%20higher%20in%20patients%20with%20AF%20before%20%283.4%25%20vs%201.2%25%2C%20P%5Cu00a0%26lt%3B%5Cu00a0%200.001%29%20and%20after%20propensity%20matching%20%283.4%25%20vs%201.7%25%2C%20P%5Cu00a0%3D%5Cu00a00.021%29%20but%20did%20not%20differ%20between%20the%20paroxysmal%20AF%20and%20the%20no%20AF%20groups%20%28P%5Cu00a0%3D%5Cu00a00.205%29.%20In%20the%20matched%20cohorts%2C%20both%20AF%20and%20paroxysmal%20AF%20groups%20were%20associated%20with%20a%20higher%20rate%20of%20cardiogenic%20shock%20%28AF%2C%20P%5Cu00a0%26lt%3B%5Cu00a00.001%3B%20paroxysmal%20AF%2C%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29%2C%20ventricular%20arrhythmia%20%28AF%2C%20P%5Cu00a0%3D%5Cu00a00.002%3B%20paroxysmal%20AF%2C%20P%5Cu00a0%3D%5Cu00a00.02%29%2C%20acute%20kidney%20injury%20%28AF%2C%20P%5Cu00a0%3D%5Cu00a00.007%3B%20paroxysmal%20AF%2C%20P%5Cu00a0%3D%5Cu00a00.008%29%2C%20and%20acute%20respiratory%20failure%20%28AF%2C%20P%5Cu00a0%26lt%3B%5Cu00a00.001%3B%20paroxysmal%20AF%2C%20P%5Cu00a0%26lt%3B%5Cu00a00.001%29%20compared%20with%20the%20no%20AF%20group.%5CnCONCLUSIONS%3A%20Although%20AF%20was%20associated%20with%20increased%20in-hospital%20mortality%2C%20paroxysmal%20AF%20did%20not%20affect%20in-hospital%20mortality%2C%20suggesting%20a%20higher%20AF%20burden%20is%20associated%20with%20worse%20clinical%20outcome%20in%20patients%20with%20TCM.%22%2C%22date%22%3A%22Jul%2003%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.amjms.2022.06.019%22%2C%22ISSN%22%3A%221538-2990%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22LV239TYN%22%2C%22CH4JXISP%22%2C%22FA6KSIY7%22%5D%2C%22dateModified%22%3A%222023-02-14T20%3A18%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22LJXRLHDP%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLi%2C%20P.%2C%20Wang%2C%20Y.%2C%20Liang%2C%20J.%20et%20al.%20%282022%29.%20Takotsubo%20syndrome%20and%20respiratory%20diseases%3A%20A%20systematic%20review%20M.%20B%26%23xE4%3Bck%20%28ed.%29%2C.%20%26lt%3Bi%26gt%3BEuropean%20Heart%20Journal%20Open%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%20oeac009.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fehjopen%5C%2Foeac009%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fehjopen%5C%2Foeac009%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Takotsubo%20syndrome%20and%20respiratory%20diseases%3A%20A%20systematic%20review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pengyang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanxuan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Liang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinyu%22%2C%22lastName%22%3A%22Zuo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiuyue%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akil%20Adrian%22%2C%22lastName%22%3A%22Sherif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jingyi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yidan%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zirui%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Man%22%2C%22lastName%22%3A%22Dong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Teng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A%20F%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xin%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lingling%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chengyue%22%2C%22lastName%22%3A%22Jin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiying%22%2C%22lastName%22%3A%22Dai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jianjun%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Magnus%22%2C%22lastName%22%3A%22B%5Cu00e4ck%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Takotsubo%20syndrome%20%28TTS%29%20is%20a%20rare%20cardiovascular%20condition%20characterized%20by%20reversible%20ventricular%20dysfunction%20and%20a%20presentation%20resembling%20that%20of%20acute%20myocardial%20infarction.%20An%20increasing%20number%20of%20studies%20has%20shown%20the%20association%20of%20respiratory%20diseases%20with%20TTS.%20Here%2C%20we%20comprehensively%20reviewed%20the%20literature%20and%20examined%20the%20available%20evidence%20for%20this%20association.%20After%20searching%20PubMed%2C%20EMBASE%2C%20and%20Cochrane%20Library%20databases%2C%20two%20investigators%20independently%20reviewed%203117%20studies%20published%20through%20May%202021.%20Of%20these%20studies%2C%2099%20met%20the%20inclusion%20criteria%20%28n%5Cu2009%3D%5Cu2009108%20patients%29.%20In%20patients%20with%20coexisting%20respiratory%20disease%20and%20TTS%2C%20the%20most%20common%20TTS%20symptom%20was%20dyspnoea%20%2870.48%25%29%2C%20followed%20by%20chest%20pain%20%2824.76%25%29%20and%20syncope%20%282.86%25%29.%20The%20most%20common%20type%20of%20TTS%20was%20apical%2C%20accounting%20for%2081.13%25%20of%20cases%2C%20followed%20by%20the%20midventricular%20%288.49%25%29%2C%20basal%20%288.49%25%29%2C%20and%20biventricular%20%281.89%25%29%20types.%20Among%20the%20TTS%20cases%2C%2039.82%25%20were%20associated%20with%20obstructive%20lung%20disease%20and%2038.89%25%20were%20associated%20with%20pneumonia.%20Coronavirus%20disease%202019%20%28COVID-19%29%2C%20which%20has%20been%20increasingly%20reported%20in%20patients%20with%20TTS%2C%20was%20identified%20in%2029%20of%2042%20%2869.05%25%29%20patients%20with%20pneumonia.%20The%20overall%20mortality%20rate%20for%20patients%20admitted%20for%20respiratory%20disease%20complicated%20by%20TTS%20was%2012.50%25.%20Obstructive%20lung%20disease%20and%20pneumonia%20are%20the%20most%20frequently%20identified%20respiratory%20triggers%20of%20TTS.%20Medications%20and%20invasive%20procedures%20utilized%20in%20managing%20respiratory%20diseases%20may%20also%20contribute%20to%20the%20development%20of%20TTS.%20Furthermore%2C%20the%20diagnosis%20of%20TTS%20triggered%20by%20these%20conditions%20can%20be%20challenging%20due%20to%20its%20atypical%20presentation.%20Future%20prospective%20studies%20are%20needed%20to%20establish%20appropriate%20guidelines%20for%20managing%20respiratory%20disease%20with%20concurrent%20TTS.%22%2C%22date%22%3A%22Mar%2015%202022%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1093%5C%2Fehjopen%5C%2Foeac009%22%2C%22ISSN%22%3A%222752-4191%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fehjopen%5C%2Farticle%5C%2Fdoi%5C%2F10.1093%5C%2Fehjopen%5C%2Foeac009%5C%2F6535735%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22LV239TYN%22%2C%22CH4JXISP%22%2C%22LNSKD4V3%22%5D%2C%22dateModified%22%3A%222022-03-29T18%3A10%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22VXMX4AQ8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lu%20et%20al.%22%2C%22parsedDate%22%3A%222021-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLu%2C%20X.%2C%20Li%2C%20P.%2C%20Teng%2C%20C.%20et%20al.%20%282021%29.%20Prognostic%20factors%20of%20Takotsubo%20cardiomyopathy%3A%20a%20systematic%20review.%20%26lt%3Bi%26gt%3BESC%20Heart%20Fail%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%203663%26%23x2013%3B3689.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fehf2.13531%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fehf2.13531%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prognostic%20factors%20of%20Takotsubo%20cardiomyopathy%3A%20a%20systematic%20review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaojia%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pengyang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Teng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ling%22%2C%22lastName%22%3A%22Jin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chenlin%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bin%22%2C%22lastName%22%3A%22Wang%22%7D%5D%2C%22abstractNote%22%3A%22Takotsubo%20cardiomyopathy%20%28TCM%29%2C%20characterized%20by%20reversible%20ventricular%20dysfunction%2C%20has%20similar%20mortality%20to%20acute%20coronary%20syndrome.%20With%20the%20growing%20interest%20in%20the%20diagnosis%20of%20and%20interventions%20for%20TCM%2C%20many%20risk%20factors%20had%20been%20found%20to%20affect%20the%20prognosis%20of%20TCM%20patients%2C%20such%20as%20age%2C%20sex%2C%20and%20pre-existing%20diseases.%20Because%20of%20the%20incomplete%20understanding%20of%20the%20pathophysiologic%20mechanism%20in%20TCM%2C%20evidence-based%20medical%20therapy%20for%20this%20condition%20is%20lacking.%20Early%20intervention%20on%20risk%20factors%20may%20improve%20the%20outcomes%20of%20TCM.%20In%20this%20review%2C%20we%20sought%20to%20provide%20up-to-date%20evidence%20on%20risk%20factors%20and%20medical%20therapies%20that%20affect%20TCM%20outcome.%20We%20found%20that%20male%20sex%2C%20physical%20triggers%2C%20and%20certain%20comorbidities%20such%20as%20chronic%20kidney%20disease%2C%20malignant%20disease%2C%20higher%20body%20mass%20index%2C%20sepsis%2C%20chronic%20obstructive%20pulmonary%20disease%2C%20and%20anaemia%20were%20associated%20with%20poor%20TCM%20prognosis.%20In%20contrast%2C%20race%2C%20hyperlipidaemia%2C%20diabetes%20mellitus%2C%20and%20mood%20disorders%20were%20not%20clearly%20associated%20with%20TCM%20prognosis.%20We%20also%20reviewed%20the%20effect%20of%20medical%20therapies%20on%20TCM%20outcome%2C%20including%20angiotensin-converting%20enzyme%20inhibitors%5C%2Fangiotensin%20receptor%20blockers%2C%20%5Cu03b2-blockers%2C%20calcium%20channel%20blockers%2C%20and%20statins.%20The%20evidence%20that%20these%20medications%20confer%20a%20survival%20benefit%20on%20TCM%20patients%20is%20limited.%20Understanding%20these%20prognostic%20factors%20could%20help%20develop%20risk-stratification%20tools%20for%20TCM%20and%20establish%20effective%20prevention%20and%20interventions%20for%20this%20not-so-benign%20condition.%20Further%20multicentre%20clinical%20studies%20with%20large%20samples%20and%20meta-analyses%20of%20findings%20from%20previous%20studies%20are%20needed%20to%20address%20the%20inconsistent%20findings%20among%20the%20many%20potential%20risk%20factors%20for%20TCM.%22%2C%22date%22%3A%22Oct%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fehf2.13531%22%2C%22ISSN%22%3A%222055-5822%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22LV239TYN%22%2C%22CH4JXISP%22%5D%2C%22dateModified%22%3A%222021-10-29T18%3A39%3A30Z%22%7D%7D%2C%7B%22key%22%3A%22WI8DLRGC%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Liu%20et%20al.%22%2C%22parsedDate%22%3A%222021-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BLiu%26lt%3B%5C%2Fstrong%26gt%3B%2C%20Q.%2C%20Pan%2C%20S.%2C%20%26lt%3Bstrong%26gt%3BLiu%26lt%3B%5C%2Fstrong%26gt%3B%2C%20S.%20et%20al.%20%282021%29.%20Suppressing%20Hippo%20signaling%20in%20the%20stem%20cell%20niche%20promotes%20skeletal%20muscle%20regeneration.%20%26lt%3Bi%26gt%3BStem%20Cells%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B39%26lt%3B%5C%2Fi%26gt%3B%2C%20737%26%23x2013%3B749.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fstem.3343%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fstem.3343%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Suppressing%20Hippo%20signaling%20in%20the%20stem%20cell%20niche%20promotes%20skeletal%20muscle%20regeneration%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shijie%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sui%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20T.%22%2C%22lastName%22%3A%22Willerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20F.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%5D%2C%22abstractNote%22%3A%22Lack%20of%20blood%20flow%20to%20the%20lower%20extremities%20in%20peripheral%20arterial%20disease%20causes%20oxygen%20and%20nutrient%20deprivation%20in%20ischemic%20skeletal%20muscles%2C%20leading%20to%20functional%20impairment.%20Treatment%20options%20for%20muscle%20regeneration%20in%20this%20scenario%20are%20lacking.%20Here%2C%20we%20selectively%20targeted%20the%20Hippo%20pathway%20in%20myofibers%2C%20which%20provide%20architectural%20support%20for%20muscle%20stem%20cell%20niches%2C%20to%20facilitate%20functional%20muscle%20recovery%20in%20ischemic%20extremities%20by%20promoting%20angiogenesis%2C%20neovascularization%2C%20and%20myogenesis.%20We%20knocked%20down%20the%20core%20Hippo%20pathway%20component%2C%20Salvador%20%28SAV1%29%2C%20by%20using%20an%20adeno-associated%20virus%209%20%28AAV9%29%20vector%20expressing%20a%20miR30-based%20triple%20short-hairpin%20RNA%20%28shRNA%29%2C%20controlled%20by%20a%20muscle-specific%20promoter.%20In%20a%20mouse%20hindlimb-ischemia%20model%2C%20AAV9%20SAV1%20shRNA%20administration%20in%20ischemic%20muscles%20induced%20nuclear%20localization%20of%20the%20Hippo%20effector%20YAP%2C%20accelerated%20perfusion%20restoration%2C%20and%20increased%20exercise%20endurance.%20Intravascular%20lectin%20labeling%20of%20the%20vasculature%20revealed%20enhanced%20angiogenesis.%20Using%205-ethynyl-2%26%23039%3B-deoxyuridine%20to%20label%20replicating%20cellular%20DNA%20in%20vivo%2C%20we%20found%20SAV1%20knockdown%20concurrently%20increased%20paired%20box%20transcription%20factor%20Pax7%2B%20muscle%20satellite%20cell%20and%20CD31%2B%20endothelial%20cell%20proliferation%20in%20ischemic%20muscles.%20To%20further%20study%20Hippo%20suppression%20in%20skeletal%20muscle%20regeneration%2C%20we%20used%20a%20cardiotoxin-induced%20muscle%20damage%20model%20in%20adult%20%2812-15%5Cu2009weeks%20old%29%20and%20aged%20mice%20%2826-month%20old%29.%20Two%20weeks%20after%20delivery%20of%20AAV9%20SAV1%20shRNA%20into%20injured%20muscles%2C%20the%20distribution%20of%20regenerative%20myofibers%20shifted%20toward%20a%20larger%20cross-sectional%20area%20and%20increased%20capillary%20density%20compared%20with%20mice%20receiving%20AAV9%20control.%20Together%2C%20these%20findings%20suggest%20our%20approach%20may%20have%20clinical%20promise%20in%20regenerative%20therapy%20for%20leg%20ischemia%20and%20muscle%20injury.%22%2C%22date%22%3A%22Jun%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fstem.3343%22%2C%22ISSN%22%3A%221549-4918%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NNUFWYNJ%22%2C%22WGZKEVDQ%22%2C%227IGCL8QC%22%2C%22LV239TYN%22%2C%22WK6JRAQQ%22%2C%22CH4JXISP%22%5D%2C%22dateModified%22%3A%222021-06-08T15%3A37%3A44Z%22%7D%7D%2C%7B%22key%22%3A%223ZLRTMSR%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20et%20al.%22%2C%22parsedDate%22%3A%222021-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLi%2C%20P.%2C%20Dai%2C%20Q.%2C%20Cai%2C%20P.%20et%20al.%20%282021%29.%20Identifying%20different%20phenotypes%20in%20takotsubo%20cardiomyopathy%20by%20latent%20class%20analysis.%20%26lt%3Bi%26gt%3BESC%20Heart%20Fail%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%20555%26%23x2013%3B565.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fehf2.13117%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fehf2.13117%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Identifying%20different%20phenotypes%20in%20takotsubo%20cardiomyopathy%20by%20latent%20class%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pengyang%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiying%22%2C%22lastName%22%3A%22Dai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Teng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%5D%2C%22abstractNote%22%3A%22AIMS%3A%20This%20study%20sought%20to%20determine%20whether%20clinical%20clusters%20exist%20in%20takotsubo%20cardiomyopathy.%20Takotsubo%20cardiomyopathy%20%28TCM%29%20is%20a%20heterogeneous%20disorder%20with%20a%20complex%2C%20poorly%20understood%20pathogenesis.%20To%20better%20understand%20the%20heterogeneity%20of%20TCM%2C%20we%20identified%20different%20clinical%20phenotypes%20in%20a%20large%20sample%20of%20TCM%20patients%20by%20using%20latent%20class%20analysis%20%28LCA%29.%5CnMETHODS%20AND%20RESULTS%3A%20Using%20the%20National%20Inpatient%20Sample%20%28NIS%29%20database%2C%20we%20identified%203139%20patients%20admitted%20to%20hospitals%20in%202016-2017%20with%20a%20primary%20diagnosis%20of%20TCM.%20We%20performed%20LCA%20based%20on%20several%20patient%20demographics%20and%20comorbidities%3A%20age%2C%20sex%2C%20hypertension%2C%20hyperlipidaemia%2C%20diabetes%20mellitus%2C%20obesity%2C%20current%20smoking%2C%20asthma%2C%20chronic%20obstructive%20pulmonary%20disease%20%28COPD%29%2C%20and%20anxiety%20and%20depressive%20disorders.%20We%20then%20repeated%20LCA%20separately%20with%20the%20NIS%202016%20and%202017%20data%20sets%20and%20performed%20a%20robust%20test%20to%20validate%20our%20results.%20We%20also%20compared%20in-hospital%20outcomes%20among%20the%20different%20clusters%20identified%20by%20LCA.%20Four%20patient%20clusters%20were%20identified.%20C1%20%28n%5Cu00a0%3D%5Cu00a01228%2C%2039.4%25%29%20had%20the%20highest%20prevalence%20of%20hyperlipidaemia%20%2893.4%25%29%2C%20hypertension%20%2861.6%25%29%2C%20and%20diabetes%20%2834.3%25%29.%20In%20C2%20%28n%5Cu00a0%3D%5Cu00a0440%2C%2014.0%25%29%2C%20all%20patients%20had%20COPD%2C%20and%20many%20were%20smokers%20%2845.8%25%29.%20C3%20%28n%5Cu00a0%3D%5Cu00a0376%2C%2011.8%25%29%20largely%20comprised%20patients%20with%20anxiety%20disorders%20%2898.4%25%29%20and%20depressive%20disorders%20%2880.1%25%29.%20C4%20%28n%5Cu00a0%3D%5Cu00a01097%2C%2034.8%25%29%20comprised%20patients%20with%20isolated%20TCM%20and%20few%20comorbidities.%20Among%20all%20clusters%2C%20C1%20had%20the%20lowest%20in-hospital%20mortality%20%281.0%25%29%20and%20the%20shortest%20length%20of%20stay%20%283.2%5Cu00a0%5Cu00b1%5Cu00a03.1%5Cu00a0days%29%2C%20whereas%20C2%20had%20the%20highest%20in-hospital%20mortality%20%283.4%25%29.%5CnCONCLUSIONS%3A%20Using%20LCA%2C%20we%20identified%20four%20clinical%20phenotypes%20of%20TCM.%20These%20may%20reflect%20different%20pathophysiological%20processes%20in%20TCM.%20Our%20findings%20may%20help%20identify%20treatment%20targets%20and%20select%20patients%20for%20future%20clinical%20trials.%22%2C%22date%22%3A%22Feb%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fehf2.13117%22%2C%22ISSN%22%3A%222055-5822%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%22LV239TYN%22%2C%22CH4JXISP%22%5D%2C%22dateModified%22%3A%222021-03-22T15%3A33%3A30Z%22%7D%7D%5D%7D

Shi, A., El Haddad, J., Cai, P. et al. (2023). Mpox (monkeypox) information on TikTok: analysis of quality and audience engagement. BMJ Glob Health 8, e011138. https://doi.org/10.1136/bmjgh-2022-011138.

Chen, X., Yu, W., Zhang, J. et al. (2023). Therapeutic angiogenesis and tissue revascularization in ischemic vascular disease. J Biol Eng 17, 13. https://doi.org/10.1186/s13036-023-00330-2.

Chen, X., Cai, Q., Liang, R. et al. (2023). Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis 14, 105. https://doi.org/10.1038/s41419-023-05639-w.

Liu, Q., Pan, S., Li, P. et al. (2023). Hippo pathway inhibition promotes metabolic adaptability and antioxidant response in myoblasts. Sci Rep 13, 2232. https://doi.org/10.1038/s41598-023-29372-8.

Li, P., Jin, C., Cui, C. et al. (2022). Impact of family history of coronary artery disease on clinical outcomes in Takotsubo cardiomyopathy. J Investig Med, jim-2021-002186. https://doi.org/10.1136/jim-2021-002186.

Dai, Q., Li, P., Bose, A. et al. (2022). Association of atrial fibrillation burden with in-hospital outcomes in patients with Takotsubo cardiomyopathy. Am J Med Sci, S0002-9629(22)00296–8. https://doi.org/10.1016/j.amjms.2022.06.019.

Li, P., Wang, Y., Liang, J. et al. (2022). Takotsubo syndrome and respiratory diseases: A systematic review M. Bäck (ed.),. European Heart Journal Open 2, oeac009. https://doi.org/10.1093/ehjopen/oeac009.

Lu, X., Li, P., Teng, C. et al. (2021). Prognostic factors of Takotsubo cardiomyopathy: a systematic review. ESC Heart Fail 8, 3663–3689. https://doi.org/10.1002/ehf2.13531.

Liu, Q., Pan, S., Liu, S. et al. (2021). Suppressing Hippo signaling in the stem cell niche promotes skeletal muscle regeneration. Stem Cells 39, 737–749. https://doi.org/10.1002/stem.3343.

Li, P., Dai, Q., Cai, P. et al. (2021). Identifying different phenotypes in takotsubo cardiomyopathy by latent class analysis. ESC Heart Fail 8, 555–565. https://doi.org/10.1002/ehf2.13117.